| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000032377 |
| Receipt No. | R000034828 |
| Scientific Title | Esophageal motility disorders caused by esophageal eosinophilia |
| Date of disclosure of the study information | 2019/03/31 |
| Last modified on | 2022/10/27 (Ver. 5) |
| Basic information | ||
| Public title | Esophageal motility disorders caused by esophageal eosinophilia | |
| Acronym | Esophageal motility disorders by eosinophil infiltration | |
| Scientific Title | Esophageal motility disorders caused by esophageal eosinophilia | |
| Scientific Title:Acronym | Esophageal motility disorders by eosinophil infiltration | |
| Region |
|
|
| Condition | ||
| Condition | Esophageal motility disorders
Eosinophilic esophagitis |
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the esophageal motility in the patients with eosinophilic esophagitis , the impact of eosinophil infiltration on primary esophageal motility disorders, thus we will find the useful knowledge for the strategy to choose the best treatment for the patients with esophageal motility disorders |
| Basic objectives2 | Others |
| Basic objectives -Others | Pathophysiological investigation |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The prevalence of esophageal motility disorders in the patients with eosinophilic infiltration into esophageal mucosa |
| Key secondary outcomes | The prevalence of eosinophil infiltration among eosinophilic esophagitis |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who underwent both esophageal manometry and endoscopic biopsy to determine eosinophil infiltration in esophageal mucosa | |||
| Key exclusion criteria | None | |||
| Target sample size | 306 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Gunma University Hospital | ||||||
| Division name | Gastroenterology and Hepatology | ||||||
| Zip code | 371-8511 | ||||||
| Address | 3-39-15 Showa-machi, Maebashi, Gunma | ||||||
| TEL | 0272208137 | ||||||
| uraoka@gunma-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Gunma University Hospital | ||||||
| Division name | Gastroenterology and Hepatology | ||||||
| Zip code | 371-8511 | ||||||
| Address | 3-39-15 Showa-machi, Maebashi, Gunma | ||||||
| TEL | 027-220-8137 | ||||||
| Homepage URL | |||||||
| hhosaka@gunma-u.ac.jp | |||||||
| Sponsor | |
| Institute | Gunma University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Gunma University Hospital |
| Address | 3-39-22Showa-machi |
| Tel | 0272208137 |
| hitotaisho-ciru@ml.gunma-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 群馬大学医学部附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 18 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Unpublished
|
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000034828 |